<DOC>
	<DOCNO>NCT01709214</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy GRT6005 compare placebo patient moderate severe chronic pain due osteoarthritis ( OA ) knee . This study include maximum 21 day Screening Period follow 15-week Double-blind Treatment Period 4-7 day Safety Follow-up period . Patients eligible Double-blind Treatment Period randomize one follow treatment group : GRT6005 high-dose range ( 400 , 600 800 mcg ) , GRT6005 low-dose range ( 200 , 300 400 mcg ) , oxycodone CR ( Controlled Release ) dose range ( 10 , 20 , 30 , 40 50 mg ) placebo .</brief_summary>
	<brief_title>Safety Efficacy Study GRT6005 Patients With Osteoarthritis ( OA ) Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Diagnosis osteoarthritis ( OA ) knee OA knee pain present least 3 month OA knee pain predominant ( ie , painful ) pain condition Patients require medication least 4 7 day per week treat OA knee pain least 1 month . Dissatisfaction current OA knee pain treatment willingness stop take pain medication except study drug allow rescue medication Average daily pain rating least 5 0 10 point numerical rating scale 1 week prior randomization Female patient either postmenopausal , surgically sterile practice medically acceptable method contraception Male patient either status postbilateral vasectomy use barrier contraception Knee pain due disorder OA Other pain confound assessment , contribute , pain reference knee Surgery reference knee within 6 month Screening history joint replacement surgery reference knee Trauma reference knee within 6 month Screening active symptom Steroid injection reference knee within 3 month Screening Hyaluronic acid injection reference knee within 6 month Screening Body Mass Index &gt; 40 kg/m2 Patient protocolexcluded clinically significant medical , surgical , medication history would limit patient 's ability complete participate clinical trial could confound study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Pain</keyword>
	<keyword>Chronic</keyword>
	<keyword>OA</keyword>
	<keyword>Arthritis</keyword>
</DOC>